REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>

Hikma PharmaceuticalsAnnouncement

06/09/2014 22:24

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20140728:nRSb4449Na


RNS Number : 4449N
Hikma Pharmaceuticals Plc
28 July 2014 
 
Annex DTR3 
 
Notification of Transactions of Directors/Persons Discharging Managerial
Responsibility and Connected Persons 
 
All relevant boxes should be completed in block capital letters 
 
 1.   Name of the Issuer: Hikma Pharmaceuticals PLC                                                                                                                                                            2.   State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006):DTR 3.1.2 R  
 3.   Name of person discharging managerial responsibilities/director:Samih Darwazah, Said Darwazah, Mazen Darwazah and Ali Al-Husry                                                                           4.   State whether notification relates to a person connected with a person discharging managerial responsibilities/ director named in 3 and identify the connected person:Yes:  Darhold Limited                                                                    
 5.   Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest:Beneficial interest Darhold Limited                    6.   Description of shares (including class), debentures or derivatives or financial instruments relating to shares:Ordinary Shares                                                                                                                                 
 7.   Name of registered shareholders(s) and, if more than one, the number of shares held by each of them:Bank Audi Sal                                                                                        8.   State the nature of the transaction:Release of a security over 1,700,000 Ordinary Shares                                                                                                                                                                       
 9.   Number of shares, debentures or financial instruments relating to shares acquired:None                                                                                                                   10.  Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage):N/A                                                                                                                           
 11.  Number of shares, debentures or financial instruments relating to shares disposed:None                                                                                                                   12.  Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage):N/A                                                                                                                           
 13.  Price per share or value of transaction:N/A                                                                                                                                                              14.  Date and place of transaction:London, 15 July 2014                                                                                                                                                                                                             
 15.  Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage):57,183,028 - 28.81 per cent  16.  Date issuer informed of transaction:24 July 2014                                                                                                                                                                                                               
 
 
 If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes  
 17.                                                                                                                      Date of grant                                                                                               18.  Period during which or date on which exercisable                                     
 19.                                                                                                                      Total amount paid (if any) for grant of the option                                                          20.  Description of shares or debentures involved (class and number)                      
 21.                                                                                                                      Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise  22.  Total number of shares or debentures over which options held following notification  
 23.                                                                                                                      Any additional information                                                                                  24.  Name of contact and telephone number for queries                                     
 
 
 Name of authorised official or issuer responsible for making notification  
 Peter Speirs, Company Secretary, Hikma Pharmaceuticals PLC                 
 Date of notification:  28 July 2014                                        
 
 
Notes: 
 
This form is intended for use by an issuer to make a RIS notification required
by DTR 3.1.4 
 
(1)           An issuer making a notification in respect of a transaction
relating to the shares or debentures of the issuer should complete boxes 1 to
16, 23 and 24. 
 
(2)           An issuer making a notification in respect of a derivative
relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,
16, 23 and 24. 
 
(3)           An issuer making a notification in respect of options granted to
a director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24. 
 
(4)           An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other than a debenture)
should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. 
 
This information is provided by RNS
The company news service from the London Stock Exchange